Navigation Links
Transgenomic Licenses IP From IntegraGen to Develop Genetic Test for Autism
Date:2/24/2010

class="xn-person">Craig Tuttle, president and chief executive officer of Transgenomic. "We believe that the use of this test in conjunction with standard diagnostic tools will allow for the earlier diagnosis of autism, and importantly, the more timely initiation of treatment plans for these children.  We look forward to adding this proprietary test to our growing commercial offerings."

Autism is a developmental disorder that causes significant social, communication and behavioral challenges in children.  The Centers for Disease Control and Prevention estimates that one in 110 children in the U.S. has an autism-related disorder, and that the incidence of autism is up 57 percent from 2002 to 2006.  Even though parents typically express concerns about their child's developmental progress before the age of three, the average age of diagnoses is not until 53 months.  Early intervention has been shown to be effective in improving a child's ability to develop into a competent adult.  Children with a sibling who has been diagnosed with autism are at a significantly greater risk of developing the disorder.

"IntegraGen is excited about the opportunity for our technology to be commercialized by Transgenomic," said Dr. Bernard Courtieu, chief executive officer of IntegraGen. "We will continue our gene discovery efforts to further our understanding of autism while focusing on other diseases where molecular tests may help with patient diagnosis and disease management."


'/>"/>
SOURCE Transgenomic, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Transgenomic Presents at 12th Annual BIO CEO & Investor Conference
2. Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit
3. Transgenomic, Inc. Reports Third Quarter 2009 Results
4. Transgenomic and Power3 Medical Report Identification of Abnormal Serum Proteins in Parkinsons Disease
5. Transgenomic, Inc. Reports Second Quarter 2009 Results
6. Reminder: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast
7. Webcast Alert: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast
8. Transgenomic, Inc. Announces Appointment of New Board Members
9. Transgenomic, Inc. Reports First Quarter 2009 Results
10. Reminder: Transgenomic Inc. Announces First Quarter 2009 Earnings Release Conference Call Webcast
11. Transgenomic and Power3 Medical Introduce NuroPro(R) Tests for Alzheimers and Parkinsons Diseases at AAN Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... According to a new market research report ... and Joint) Market (By Technology - Stem Cell ... Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic ... Share, Growth, Trends and Forecast, 2013 - 2019" ... was valued at USD 2.6 billion in 2012 ...
(Date:7/28/2014)... CA and Annapolis Junction, MD (PRWEB) July 28, 2014 ... and research leader in personalized medicine, will be exhibiting ... services at this year’s International Spine Intervention Society’s ... take place July 30th-August 3rd, at the Hyatt Regency, ... designed to enhance the knowledge and clinical competence of ...
(Date:7/28/2014)... 28, 2014 Research and Markets ... Biology Market 2014-2018" report to their offering. ... term synthetic biology covers the designing and engineering of ... as the redesigning of natural biological systems that provide ... a form of extreme genetic engineering because it not ...
(Date:7/28/2014)... 28, 2014 /PRNewswire/ -   JOLT , a leading ... to join its growing portfolio of startups. Next-level tech ... Toronto,s JOLT accelerator, and Cohort four is ... Since its launch in July 2012, ...  $7.5M of financing. Now at 23 investments, JOLT,s portfolio ...
Breaking Biology Technology:Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2Global Synthetic Biology Market 2014-2018 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 3
... , , HONG KONG, Dec. ... Company") (NYSE: CO ), China,s leading provider of ... stem cell storage services, today announced that the underwriters of ... portion of their over-allotment option, which will result in the ...
... EMERYVILLE, Calif., Dec. 29 Bionovo, Inc. (Nasdaq: BNVI ... on the anti-tumor mechanism of BN107. The results of ... , describe the potential molecular mechanisms mediating the selective pro-apoptotic ... (ER-) breast cancer cells. , Despite favorable advances that treatment ...
... , , , NEW YORK, Dec. 28 ... New Jersey, recently started using Twitter, the popular social networking tool, as ... new products and beauty trends to his patients and anyone else interested ... my patients on a more personal level. It provides a fun, easy ...
Cached Biology Technology:China Cord Blood Corporation Announces Partial Exercise of Over-Allotment Option 2China Cord Blood Corporation Announces Partial Exercise of Over-Allotment Option 3Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer 2Bionovo Announces Publication Describing First Novel Dual mTOR Inhibitor, BN107, for the Treatment of Breast Cancer 3New York Plastic Surgeon Transforms His Practice Using Twitter Status Updates 2New York Plastic Surgeon Transforms His Practice Using Twitter Status Updates 3
(Date:7/25/2014)... July 25, 2014 In the first broad-scale estimate of ... scientists and collaborators calculated that trees are saving more ... incidences of acute respiratory symptoms. , While trees, pollution ... less than 1 percent, the impacts of that improvement ... the reduced air pollution at nearly $7 billion every ...
(Date:7/25/2014)... Terra satellite show the different areas that have been affected ... The burn scars show up as reddish-brown splotches of color ... the remote parts of Eastern Russia in the Sakha Republic. ... instrument, it is still possible to see the smoke rising ... below show the devastating number of fires that have plagued ...
(Date:7/25/2014)... and disrupted brain development is an essential part ... largely unknown. However, thanks to funding from the ... University (GW) researcher Anthony-Samuel LaMantia, Ph.D. may be ... to these key questions in the field of ... and physiology at the GW School of Medicine ...
Breaking Biology News(10 mins):First national study finds trees saving lives, reducing respiratory problems 2GW researcher receives grant to answer the how and why of autism during development 2
... Fairbanks, Alaska -- As the Arctic warms, greenhouse gases ... significantly higher levels than previous estimates, according to survey ... 30 issue of the journal Nature. Permafrost thaw ... deforestation, say the authors, but the effect on ...
... of North Carolina at Chapel Hill have shown that it ... an effort to create the ultimate vehicle for gene therapy. ... side effects from using a "chimeric" virus to deliver replacement ... dystrophy. "This trial demonstrates that gene therapy is no ...
... , MONTREAL, November 30, 2011 Take a Petri dish ... distinctive of the toxins that make up the fossil fuel. ... sit for two weeks in an incubator, and surprise, the ... petroleum!" says Mohamed Hijri, a professor of biological sciences and ...
Cached Biology News:Abrupt permafrost thaw increases climate threat 2Clinical trial for muscular dystrophy demonstrates safety of customized gene therapy 2Petroleum-eating mushrooms 2Petroleum-eating mushrooms 3Petroleum-eating mushrooms 4
5(S)-HETE-d8 is used as an internal standard for the quantification of 5(S)-HETE by stable isotope dilution mass spectrometry....
Full-length cDNA clone CS0DJ013YG01 of T cells (Jurkat cell line) of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86SZ3] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
...
...
Biology Products: